P/E của cổ phiếu AZN là bao nhiêu?

ASTRAZENECA PLC (AZN) hiện giao dịch ở mức P/E 25.81 lần.

ROE của cổ phiếu AZN là bao nhiêu?

ASTRAZENECA PLC có tỷ suất lợi nhuận trên vốn chủ sở hữu (ROE) 20.73%.

Tỷ suất cổ tức của AZN là bao nhiêu?

ASTRAZENECA PLC có tỷ suất cổ tức 1.26%.

Điểm chất lượng (Quality Score) của AZN là bao nhiêu?

AI của chúng tôi đánh giá chất lượng tài chính tổng thể của AZN ở mức 92/100, dựa trên khả năng sinh lời, tăng trưởng, nợ và độ ổn định lợi nhuận.

Bây giờ có nên mua cổ phiếu AZN không?

Điểm AI Timing của AZN là 26/100, thể hiện mức độ hấp dẫn tương đối của giá hiện tại theo tín hiệu kỹ thuật và momentum — nên cân nhắc cùng điểm chất lượng và kế hoạch đầu tư của bạn.

Cổ phiếu AZN thuộc ngành nào?

ASTRAZENECA PLC được xếp vào ngành Healthcare >> Drug Manufacturers - General trên sàn NYSE

Cổ phiếu AZN (NYSE) | ASTRAZENECA PLC

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-06-30)

AZN AI Analysis Summary

Our AI summary for AZN: ASTRAZENECA PLC (NYSE), Healthcare >> Drug Manufacturers - General sector. The stock currently trades at a P/E of 25.81, ROE of 20.73%, a dividend yield of 1.26%. Its financial Quality Score stands at 92/100 — fundamentals stronger than most of the market. The AI Timing Score is 26/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

AZN

ASTRAZENECA PLC

USD 169.64

-1.70 (-0.99%) Day Change

Watchlist Portfolio Compare Chart

25.81

P/E

0.60

D/E

20.7%

ROE

9.0%

ROA

1.26%

Div Yield

0.53

PEG

ASTRAZENECA PLC
TYPE: STOCK
MARKET: NYSE

Compare Watchlist Myport

USD 169.64 Price -1.70 (-0.99%) Day Change	NEWS SCORE: 84

AZN Chất lượng tổng thể của cố phiếu Xuất sắc ( Chất lượng = 92) nhưng Thời điểm mua ...(Sign In to See)...

Loading chart...

92 QUALITY

Signal: OUTPERFORM

Signal Description: Company financial health is Good

Reason: ROA quá thấp so với ROE

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt lắm , Sức khỏe tài chính Không tốt lắm , và khả năng kiếm lợi nhuận Tốt , ...

Yếu tố Chất lượng

54%

In Recommendations?	In "Invest - ROOKIE" Section
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	84
Magic Formula Rank by ROA	1233
Magic Formula Rank by ROE	1233
Magic Formula Rank by ROIC	1512
Price	169.64
PBV / Sector	5.34 / 2.68
Earning Per Share	6.57

PE / Sector	25.81 / 27.65
PEG or PE/Growth / Sector	0.53 / 0.28 GOOD
Average 1M Daily Value	469.65 M GREAT
Average 1W Daily Value	457.47 M GREAT

Yếu tố Kỹ thuật

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Sức khỏe tài chính

52%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Khả năng kiếm lợi nhuận

72%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	17.02 / 17.30 GOOD
NPM Average (%) / Sector	13.58 / 17.60 GOOD
NPM Change Average (%) / Sector	26.78 / 92.67 GREAT
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	9.00 / 8.73
ROA Average (%) / Sector	6.81 / 8.56
ROA Change Average (%) / Sector	30.18 / 94.23 GREAT
ROE (%) / Sector	20.73 / 26.78 GOOD
ROE Average (%) / Sector	16.63 / 13.05
ROE Change Average (%) / Sector	26.32 / 96.64 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Lợi tức cho nhà đầu tư

12%

Dividend (%) / Sector	1.26 / 2.40
Dividend Average (%) / Sector	1.98 / 3.39
Dividend Change Average (%) / Sector	-12.90 / 4.92

Chi tiết đăng ký

Analyze Date	2026-08-01 07:59:31
Symbol	AZN
Name	ASTRAZENECA PLC
Sector	Healthcare >> Drug Manufacturers - General
Market	NYSE
Listed Shares	1,550.88 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	268,766.97 / 256,404.20

Tin tức, Dự báo ước tính

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 1 Francis Crick Avenue, Cambridge, United Kingdom, CB2 0AA

Phone: 44 20 3749 5000

Website: https://www.astrazeneca.com

Employees: 96,100

Sector: Healthcare >> Drug Manufacturers - General

Description: AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Crestor, Andexxa, Onglyza, Symlin, XIGDUO XR, Atacand, Atacand HCT, Atacand Plus, Farxiga/Forxiga, Plendil, Modip, Splendil, Munobal, Flodil, Tenormin, Tenormine, Prenormine, Atenol, Zestril, Brilinta/Brilique, Komboglyze, Qtern, Wainua, Byetta, Lokelma, Seloken ZOK, Toprol-XL, Betaloc ZOK, XIGDUO, Accolate, Accoleit, Vanticon, Bricanyl Respules, Eklira Genuair/Tudorza/Bretaris, Pulmicort Turbuhaler, Symbicort Turbuhaler, Airsupra, Bricanyl Turbuhaler, Fasenra, Rhinocort, Tezspire, Bevespi Aerosphere, Daliresp/Daxas, Oxis Turbuhaler, Saphnelo, Breztri Aerosphere, Duaklir Genuair, Pulmicort Respules, and Symbicort pMDI. It also provides Beyfortus, Kavigale, Evusheld, Fluenz/FluMist, Synagis, Kanuma, Ultomiris, Koselugo, Voydeya, Soliris, Strensiq, Nexium, and other medicines. The company offers its products for ocology, cardiovascular, renal and metabolism, respiratory & immunology, vaccines and immune, and therapies rare diseases. It serves primary and specialty care physicians through distributors and local representative offices in the United Kingdom, the Americas, rest of Europe, Asia, Africa, and Australasia. It has a strategic agreement with Tempus and Pathos to develop the largest multimodal foundation model in oncology; CSPC Pharmaceutical Group Limited to advance the discovery and development of novel oral candidates, with the potential to treat diseases across multiple indications; and Nucs AI Inc. to develop AI-driven Response Prediction for Therapeutic Radioconjugates. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.